10.25384/SAGE.6396683.v1 Dorothea Buck Dorothea Buck Till FM Andlauer Till FM Andlauer Wilmar Igl Wilmar Igl Eva-Maria Wicklein Eva-Maria Wicklein Mark Mühlau Mark Mühlau Frank Weber Frank Weber Karl Köchert Karl Köchert Christoph Pohl Christoph Pohl Barry Arnason Barry Arnason Giancarlo Comi Giancarlo Comi Stuart Cook Stuart Cook Massimo Filippi Massimo Filippi Hans-Peter Hartung Hans-Peter Hartung Douglas Jeffery Douglas Jeffery Ludwig Kappos Ludwig Kappos Frederik Barkhof Frederik Barkhof Gilles Edan Gilles Edan Mark S Freedman Mark S Freedman Xavier Montalbán Xavier Montalbán Bertram Müller-Myhsok Bertram Müller-Myhsok Bernhard Hemmer Bernhard Hemmer MSJ763089_supplement – Supplemental material for Effect of <i>HLA-DRB1</i> alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials SAGE Journals 2018 Multiple sclerosis interferon beta anti-drug antibodies genetic variation HLA-DRB1 genome-wide association study 2018-03-09 12:00:00 Journal contribution https://sage.figshare.com/articles/journal_contribution/MSJ763089_supplement_Supplemental_material_for_Effect_of_i_HLA-DRB1_i_alleles_and_genetic_variants_on_the_development_of_neutralizing_antibodies_to_interferon_beta_in_the_BEYOND_and_BENEFIT_trials/6396683 <p>Supplemental material, MSJ763089_supplement for Effect of <i>HLA-DRB1</i> alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials by B Hemmer, Dorothea Buck, Mark Mühlau, Till FM Andlauer, Wilmar Igl, Eva-Maria Wicklein, Karl Köchert, Frank Weber, Christoph Pohl, Barry Arnason, Giancarlo Comi, Stuart Cook, Massimo Filippi, Hans-Peter Hartung, Douglas Jeffery, Ludwig Kappos, Frederik Barkhof, Gilles Edan, Mark S Freedman, Xavier Montalbán, Bertram Müller-Myhsok and Bernhard Hemmer in Multiple Sclerosis Journal</p>